在线时间:8:00-16:00
迪恩网络APP
随时随地掌握行业动态
扫描二维码
关注迪恩网络微信公众号
Awaiting Analysis
This vulnerability is currently awaiting analysis. DescriptionThe Omron SYSMAC Nx product family PLCs (NJ series, NY series, NX series, and PMAC series) through 2022-005-18 lack cryptographic authentication. These PLCs are programmed using the SYMAC Studio engineering software (which compiles IEC 61131-3 conformant POU code to native machine code for execution by the PLC's runtime). The resulting machine code is executed by a runtime, typically controlled by a real-time operating system. The logic that is downloaded to the PLC does not seem to be cryptographically authenticated, allowing an attacker to manipulate transmitted object code to the PLC and execute arbitrary machine code on the processor of the PLC's CPU module in the context of the runtime. In the case of at least the NJ series, an RTOS and hardware combination is used that would potentially allow for memory protection and privilege separation and thus limit the impact of code execution. However, it was not confirmed whether these sufficiently segment the runtime from the rest of the RTOS. Severity
CVSS 3.x Severity and Metrics:
NVD Analysts use publicly available information to associate vector strings and CVSS scores. We also display any CVSS information provided within the CVE List from the CNA. Note: NVD Analysts have not published a CVSS score for this CVE at this time. NVD Analysts use publicly available information at the time of analysis to associate CVSS vector strings. References to Advisories, Solutions, and ToolsBy selecting these links, you will be leaving NIST webspace. We have provided these links to other web sites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other web sites that are more appropriate for your purpose. NIST does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, NIST does not endorse any commercial products that may be mentioned on these sites. Please address comments about this page to [email protected].
Weakness Enumeration
|
2023-10-27
2022-08-15
2022-08-17
2022-09-23
2022-08-13
请发表评论